Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

  • $92.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
SELL
$83.14 - $145.99 $2.34 Million - $4.1 Million
-28,100 Closed
0 $0
Q1 2022

May 09, 2022
SELL
$110.08 - $142.92 $1.57 Million - $2.04 Million
-14,300 Reduced 33.73%
28,100 $3.33 Million
Q4 2021

Feb 07, 2022
BUY
$99.73 - $148.48 $4.23 Million - $6.3 Million
42,400 New
42,400 $5.9 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email